91 related articles for article (PubMed ID: 11769361)
21. Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics.
Palik E; Birkás KD; Faludi G; Karádi I; Cseh K
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S60-4. PubMed ID: 15955378
[TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
[TBL] [Abstract][Full Text] [Related]
23. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
24. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
25. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
26. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
Cooper GD; Harrold JA; Halford JC; Goudie AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
[TBL] [Abstract][Full Text] [Related]
27. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.
Melkersson KI; Dahl ML
Psychopharmacology (Berl); 2003 Nov; 170(2):157-66. PubMed ID: 12851739
[TBL] [Abstract][Full Text] [Related]
28. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Rane AJ
Br J Clin Pharmacol; 2001 Apr; 51(4):317-24. PubMed ID: 11318766
[TBL] [Abstract][Full Text] [Related]
29. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.
McIntyre RS; McCann SM; Kennedy SH
Can J Psychiatry; 2001 Apr; 46(3):273-81. PubMed ID: 11320682
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.
eder-Ischia U; Ebenbichler C; Fleischhacker WW
Essent Psychopharmacol; 2005; 6(2):112-7. PubMed ID: 15765795
[TBL] [Abstract][Full Text] [Related]
31. The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients.
Howes OD; Smith S; Gaughran FP; Amiel SA; Murray RM; Pilowsky LS
J Clin Psychopharmacol; 2006 Dec; 26(6):629-31. PubMed ID: 17110820
[TBL] [Abstract][Full Text] [Related]
32. [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics].
Scheen AJ; De Hert M
Rev Med Liege; 2005; 60(5-6):455-60. PubMed ID: 16035311
[TBL] [Abstract][Full Text] [Related]
33. Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study.
Sporn AL; Bobb AJ; Gogtay N; Stevens H; Greenstein DK; Clasen LS; Tossell JW; Nugent T; Gochman PA; Sharp WS; Mattai A; Lenane MC; Yanovski JA; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 2005 Sep; 44(9):925-33. PubMed ID: 16113621
[TBL] [Abstract][Full Text] [Related]
34. Side effects of atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S
Curr Pharm Des; 2004; 10(18):2219-29. PubMed ID: 15281897
[TBL] [Abstract][Full Text] [Related]
35. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.
Berk M; Fitzsimons J; Lambert T; Pantelis C; Kulkarni J; Castle D; Ryan EW; Jespersen S; McGorry P; Berger G; Kuluris B; Callaly T; Dodd S
CNS Drugs; 2007; 21(2):117-27. PubMed ID: 17284094
[TBL] [Abstract][Full Text] [Related]
36. Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.
Himmerich H; Minkwitz J; Kirkby KC
Endocr Metab Immune Disord Drug Targets; 2015; 15(4):252-60. PubMed ID: 26100432
[TBL] [Abstract][Full Text] [Related]
37. [Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations].
Jahn H; Schneider T
Nervenarzt; 2004 May; 75(5):442-50. PubMed ID: 15252884
[TBL] [Abstract][Full Text] [Related]
38. The effect of clozapine on factors controlling glucose homeostasis.
Howes OD; Gaughran FP; Amiel SA; Murray RM; Pilowsky LS
J Clin Psychiatry; 2004 Oct; 65(10):1352-5. PubMed ID: 15491238
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine.
Klemettilä JP; Solismaa A; Seppälä N; Hämäläinen M; Moilanen E; Leinonen E; Kampman O
Psychiatry Res; 2021 Dec; 306():114227. PubMed ID: 34610543
[TBL] [Abstract][Full Text] [Related]
40. Association Between Antipsychotic Medication Use and Diabetes.
Holt RIG
Curr Diab Rep; 2019 Sep; 19(10):96. PubMed ID: 31478094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
